A detailed history of Peapod Lane Capital LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 452,468 shares of AVIR stock, worth $1.59 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
452,468
Previous 452,060 0.09%
Holding current value
$1.59 Million
Previous $1.35 Billion 20.51%
% of portfolio
1.63%
Previous 1.52%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$2.55 - $3.6 $1,040 - $1,468
408 Added 0.09%
452,468 $1.63 Billion
Q1 2025

Apr 30, 2025

BUY
$2.9 - $3.52 $358,089 - $434,646
123,479 Added 37.58%
452,060 $1.35 Billion
Q4 2024

Jan 29, 2025

BUY
$2.93 - $3.82 $962,742 - $1.26 Million
328,581 New
328,581 $1.1 Billion

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $292M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Peapod Lane Capital LLC Portfolio

Follow Peapod Lane Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapod Lane Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peapod Lane Capital LLC with notifications on news.